Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device

NCT03006055 is registered in ClinicalTrials.gov with Beijing Viroad Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03006055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03006055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device
Lead sponsor
Beijing Viroad Biotechnology Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2016
Completion date
December 31, 2016
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cells.breast